- Home
- PASG vs FSEA Comparison
PASG vs FSEA Comparison
Compare PASG & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- FSEA
- Stock Information
- Founded
- PASG 2017
- FSEA 1890
- Country
- PASG United States
- FSEA United States
- Employees
- PASG N/A
- FSEA N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- FSEA Savings Institutions
- Sector
- PASG Health Care
- FSEA Finance
- Exchange
- PASG Nasdaq
- FSEA Nasdaq
- Market Cap
- PASG 42.2M
- FSEA 43.6M
- IPO Year
- PASG 2020
- FSEA N/A
- Fundamental
- Price
- PASG $0.60
- FSEA $9.96
- Analyst Decision
- PASG Strong Buy
- FSEA
- Analyst Count
- PASG 3
- FSEA 0
- Target Price
- PASG $8.00
- FSEA N/A
- AVG Volume (30 Days)
- PASG 886.7K
- FSEA 5.9K
- Earning Date
- PASG 03-03-2025
- FSEA 11-08-2024
- Dividend Yield
- PASG N/A
- FSEA N/A
- EPS Growth
- PASG N/A
- FSEA N/A
- EPS
- PASG N/A
- FSEA N/A
- Revenue
- PASG N/A
- FSEA $11,390,000.00
- Revenue This Year
- PASG N/A
- FSEA N/A
- Revenue Next Year
- PASG N/A
- FSEA N/A
- P/E Ratio
- PASG N/A
- FSEA N/A
- Revenue Growth
- PASG N/A
- FSEA N/A
- 52 Week Low
- PASG $0.45
- FSEA $8.05
- 52 Week High
- PASG $1.79
- FSEA $10.38
- Technical
- Relative Strength Index (RSI)
- PASG 43.68
- FSEA 55.91
- Support Level
- PASG $0.56
- FSEA $9.53
- Resistance Level
- PASG $0.64
- FSEA $10.09
- Average True Range (ATR)
- PASG 0.11
- FSEA 0.16
- MACD
- PASG -0.01
- FSEA -0.03
- Stochastic Oscillator
- PASG 8.69
- FSEA 54.90
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.